Logo-aim
Research Methods

1. Comparative Effectiveness Study in Multiple Sclerosis Patients Using Instrumental Variable Analysis
Hamed Hosseini, Mohammad Ali Mansournia, Seyed Massood Nabavi, Ali Asghar Akhlaghi, Jaleh Gholami, Kazem Mohammad, Reza Majdzadeh*
Arch Iran Med. 2018;21(8): 368-375.
PMID: 30113859     Scopus ID: 85057043171    
Article
PDF
XML
Cited By:
0
0
Original Article

2. Multiple Sclerosis in Tehran: Rising Prevalence alongside Stabilizing Incidence – True Increase or Enhanced Diagnosis?
Farnam Mohebi, Sharareh Eskandarieh, Mohammad Ali Mansournia, Bahram Mohajer, Mohammad Ali Sahraian*
Arch Iran Med. 2019;22(8): 429-434.
PMID: 31679345     Scopus ID: 85074428859    
Article
PDF
XML
Cited By:
6
6
History of Medicine in Iran

3. History of Multiple Sclerosis in Iran
Abdorreza Naser Moghadasi* ORCID
Arch Iran Med. 2020;23(3): 211-215.
PMID: 32126791    
Article
PDF
XML
Cited By:
0
Original Article

4. Potential Value of miR-23a for Discriminating Neuromyelitis Optica Spectrum Disorder from Multiple Sclerosis
Wessam Sharaf-Eldin* ORCID, Nirmeen Kishk, Basma Sakr, Hazem El-Hariri, Miral Refeat, Nagham ElBagoury, Mona Essawi
Arch Iran Med. 2020;23(10): 678-687. doi: 10.34172/aim.2020.86
Scopus ID: 85094846449    
Article
PDF
XML
Cited By:
3
1
Review Article

5. Biosimilars in Treatment of Multiple Sclerosis in Iran

Abdorreza Naser Moghadasi* ORCID
Arch Iran Med. 2021;24(10): 779-782. doi: 10.34172/aim.2021.115
Scopus ID: 85119402944    
Article
PDF
XML
Cited By:
2
1

Original Article

6. Clinical and Epidemiological Aspects of Late Onset Multiple Sclerosis in East-Azerbaijan, Iran; A Population-Based Study
Ehsan Nasiri ORCID, Amirreza Naseri ORCID, Pouya Abbasgholizadeh ORCID, Ali Fahidi ORCID, Mahnaz Talebi* ORCID
Arch Iran Med. 2022;25(11): 725-729. doi: 10.34172/aim.2022.114
PMCID: PMC10685859     PMID: 37543896    
Article
PDF
XML
Cited By:
1
0
Original Article

7. Economic and Social Standing of Individuals in Iran Diagnosed with Multiple Sclerosis

Fereshteh Ghadiri ORCID, Mohammad Ali Sahraian, Fereshteh Ashtari, Seyed Mohammad Baghbanian, Nastaran Majdi-Nasab, Hamidreza Hatamian, Fardin Faraji, Asghar Bayati, Ehsan Sharifipour, Nazanin Jalali, Hossein Mozhdehipanah, Hoda Kamali, Saeideh Ayoubi, Sharareh Eskandarieh* ORCID, Abdorreza Naser Moghadasi* ORCID
Arch Iran Med. 2023;26(8): 413-418. doi: 10.34172/aim.2023.63
PMCID: PMC10685736     PMID: 38301102    
Article
PDF
XML
Cited By:
0
Original Article

8. Safety and Effectiveness of Cinnomer® on Disease Characteristics, Depression, and Quality of Life of Patients with Multiple Sclerosis: A Phase IV, Post-marketing, Prospective, Multicenter Study
Abdorreza Naser Moghadasi* ORCID, Fereshteh Ashtari, Seyed Mohammad Baghbanian, Vahid Shaygannejad, Nassim Anjidani, Fereshteh Ghadiri, Behnaz Sedighi, Morteza Saeidi, Hamed Amirifard, Hormoz Ayromlou, Nahid Beladi Moghadam, Mohammad Bagher Ranjbar, Masoume Nazeri, Zahra Niknam, Fardin Faraji, Afsaneh Afsorde, Mohammad Ali Sahraian ORCID
Arch Iran Med. 2023;26(11): 647-653. doi: 10.34172/aim.2023.95
PMCID: PMC10864943     PMID: 38310425    
Article
PDF
Suppl 1
XML
Cited By:
0
Original Article

9. Impact of Alcohol Consumption on Multiple Sclerosis Using Model-based Standardization and Misclassification Adjustment Via Probabilistic Bias Analysis
Pooneh Malekifar ORCID, Saharnaz Nedjat, Ibrahim Abdollahpour, Maryam Nazemipour, Saeed Malekifar, Mohammad Ali Mansournia* ORCID
Arch Iran Med. 2023;26(10): 567-574. doi: 10.34172/aim.2023.83
PMCID: PMC10862089     PMID: 38310413    
Article
PDF
Suppl 1
XML
Cited By:
0

SCImago Journal & Country Rank

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.